Pre-operative IL13-PE38QQR in Patients With Recurrent or Progressive Malignant Glioma

Clinical trial NCT00041587 · COMPLETED

Trial details

NCT number: NCT00041587
Sponsor: INSYS Therapeutics Inc
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Malignant Glioma Glioblastoma Multiforme Anaplastic Astrocytoma Mixed Oligoastrocytoma

Start date: 2002-07-01
Primary completion: 2006-06-01
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.